INSM logo

Insmed Incorporated (INSM) Cash From Financing

Annual CFF

$1.34 B
+$1.17 B+696.15%

December 31, 2024

Summary

Performance

1-Year Change

+696.15%

3-Year Change

+118.93%

5-Year Change

+370.07%

15-Year Change

+251.89%

INSM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.76%
INSM annual cash flow from financing activities is higher than 99.76% of companies in Healthcare sector

High & Low

All-time High

$1.34 B
INSM annual cash flow from financing activities is currently at an all-time high

3-Year Low

$168.44 M
INSM annual cash flow from financing activities is currently +696.15% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
INSM previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
INSM next annual earnings announcement has not yet been scheduled

OtherINSMcash flowmetrics:

Annual CFI

-$583.17 M
INSM annual cash flow from investing activities is -$583.17 million

Annual CFO

-$683.88 M
INSM annual cash flow from operations is -$683.88 million

Annual FCF

-$705.80 M
INSM annual free cash flow is -$705.80 million

Annual CAPEX

$21.92 M
INSM annual capital expenditures is $21.92 million

Quarterly CFF

$159.31 M
-$237.90 M-59.89%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+29.24%

3-Year Change

+12654.6%

5-Year Change

+12654.6%

INSM Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.91%
INSM quarterly cash flow from financing activities is higher than 96.91% of companies in Healthcare sector

High & Low

All-time High

$781.49 M
INSM quarterly cash flow from financing activities is currently -79.62% below its historical high of $781.49 million

3-Year Low

-$399.00 K

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
INSM previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
INSM next earnings announcement has not yet been scheduled

OtherINSMcash flowmetrics:

Quarterly CFI

$131.76 M
INSM quarterly cash flow from investing activities is $131.76 million

Quarterly CFO

-$195.98 M
INSM quarterly cash flow from operations is -$195.98 million

Quarterly FCF

-$202.75 M
INSM quarterly free cash flow is -$202.75 million

Quarterly CAPEX

$6.77 M
INSM quarterly capital expenditures is $6.77 million

TTM CFF

$1.34 B
+$36.04 M+2.76%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+696.15%

3-Year Change

+70.06%

5-Year Change

+70.06%

INSM TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.65%
INSM TTM cash flow from financing activities is higher than 99.65% of companies in Healthcare sector

High & Low

All-time High

$1.34 B
INSM TTM cash flow from financing activities is currently at an all-time high

3-Year Low

$21.02 M
INSM TTM cash flow from financing activities is currently +6280.95% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
INSM previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
INSM next earnings announcement has not yet been scheduled

OtherINSMcash flowmetrics:

TTM CFI

-$583.17 M
INSM TTM cash flow from investing activities is -$583.17 million

TTM CFO

-$683.88 M
INSM TTM cash flow from operations is -$683.88 million

TTM FCF

-$705.80 M
INSM TTM free cash flow is -$705.80 million

TTM CAPEX

$21.92 M
INSM TTM capital expenditures is $21.92 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

INSM Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+696.1%+29.2%+696.1%
3 y3 years+118.9%+10000.0%+70.1%
5 y5 years+370.1%+10000.0%+70.1%

INSM Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+696.1%-79.6%>+9999.0%at high+6280.9%
5 y5-yearat high+696.1%-79.6%>+9999.0%at high+6280.9%
alltimeall timeat high>+9999.0%-79.6%+4567.3%at high>+9999.0%

Insmed Incorporated Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$1.34 B(+696.1%)
$159.31 M(-59.9%)
$1.34 B(+2.8%)
Sep 2024
-
$397.20 M(-49.2%)
$1.30 B(+43.6%)
Jun 2024
-
$781.49 M(>+9900.0%)
$909.03 M(+428.9%)
Mar 2024
-
$3.02 M(-97.5%)
$171.86 M(+2.0%)
Dec 2023
$168.44 M(-78.8%)
$123.26 M(+9768.9%)
$168.44 M(-78.6%)
Sep 2023
-
$1.25 M(-97.2%)
$788.56 M(-4.4%)
Jun 2023
-
$44.33 M(<-9900.0%)
$824.43 M(+4.8%)
Mar 2023
-
-$399.00 K(-100.1%)
$786.41 M(-0.9%)
Dec 2022
$793.27 M(+29.5%)
$743.39 M(+1902.9%)
$793.27 M(+1326.9%)
Sep 2022
-
$37.12 M(+488.1%)
$55.60 M(+164.5%)
Jun 2022
-
$6.31 M(-2.3%)
$21.02 M(-96.6%)
Mar 2022
-
$6.46 M(+13.1%)
$612.30 M(-0.0%)
Dec 2021
$612.55 M(+126.0%)
$5.71 M(+125.2%)
$612.55 M(-1.0%)
Sep 2021
-
$2.54 M(-99.6%)
$618.85 M(-0.6%)
Jun 2021
-
$597.60 M(+8815.4%)
$622.41 M(+125.9%)
Mar 2021
-
$6.70 M(-44.2%)
$275.57 M(+1.7%)
Dec 2020
$271.00 M(-5.0%)
$12.01 M(+96.8%)
$271.00 M(+1.0%)
Sep 2020
-
$6.10 M(-97.6%)
$268.23 M(+1.8%)
Jun 2020
-
$250.76 M(>+9900.0%)
$263.49 M(-7.3%)
Mar 2020
-
$2.13 M(-76.9%)
$284.36 M(-0.3%)
Dec 2019
$285.28 M(-26.2%)
$9.24 M(+580.3%)
$285.28 M(+2.4%)
Sep 2019
-
$1.36 M(-99.5%)
$278.46 M(+0.3%)
Jun 2019
-
$271.63 M(+8808.9%)
$277.71 M(+2288.7%)
Mar 2019
-
$3.05 M(+25.8%)
$11.63 M(-97.0%)
Dec 2018
$386.74 M(+1.5%)
$2.42 M(+300.5%)
$386.74 M(+0.5%)
Sep 2018
-
$605.00 K(-89.1%)
$384.75 M(-49.5%)
Jun 2018
-
$5.55 M(-98.5%)
$762.37 M(+0.5%)
Mar 2018
-
$378.17 M(>+9900.0%)
$758.69 M(+99.1%)
Dec 2017
$381.09 M(+1142.4%)
$433.00 K(-99.9%)
$381.09 M(-5.1%)
Sep 2017
-
$378.22 M(>+9900.0%)
$401.51 M(+1117.5%)
Jun 2017
-
$1.87 M(+230.8%)
$32.98 M(+5.8%)
Mar 2017
-
$565.00 K(-97.3%)
$31.16 M(+1.6%)
Dec 2016
$30.67 M(-86.5%)
$20.85 M(+115.2%)
$30.67 M(+216.8%)
Sep 2016
-
$9.69 M(>+9900.0%)
$9.68 M(+1089.3%)
Jun 2016
-
$47.00 K(-42.0%)
$814.00 K(-99.6%)
Mar 2016
-
$81.00 K(-158.3%)
$226.41 M(-0.6%)
Dec 2015
$227.80 M(+97.9%)
-$139.00 K(-116.8%)
$227.80 M(-2.8%)
Sep 2015
-
$825.00 K(-99.6%)
$234.32 M(-31.5%)
Jun 2015
-
$225.64 M(>+9900.0%)
$341.93 M(+194.2%)
Mar 2015
-
$1.48 M(-76.9%)
$116.23 M(+1.0%)
Dec 2014
$115.09 M(+68.1%)
$6.37 M(-94.1%)
$115.09 M(+5.8%)
Sep 2014
-
$108.44 M(<-9900.0%)
$108.75 M(+59.7%)
Jun 2014
-
-$60.00 K(-117.8%)
$68.11 M(-1.0%)
Mar 2014
-
$337.00 K(+764.1%)
$68.76 M(+0.5%)
Dec 2013
$68.45 M(+50.7%)
$39.00 K(-99.9%)
$68.45 M(-12.8%)
Sep 2013
-
$67.79 M(>+9900.0%)
$78.54 M(+115.9%)
Jun 2013
-
$596.00 K(+2609.1%)
$36.38 M(-20.0%)
Mar 2013
-
$22.00 K(-99.8%)
$45.48 M(+0.1%)
Dec 2012
$45.42 M
$10.13 M(-60.5%)
$45.42 M(+28.8%)
Sep 2012
-
$25.63 M(+164.3%)
$35.28 M(+266.5%)
Jun 2012
-
$9.70 M(<-9900.0%)
$9.62 M(<-9900.0%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$34.00 K(+88.9%)
-$63.00 K(+26.0%)
Dec 2011
-$50.00 K(-78.5%)
-$18.00 K(-18.2%)
-$50.00 K(+42.9%)
Sep 2011
-
-$22.00 K(-300.0%)
-$35.00 K(+169.2%)
Jun 2011
-
$11.00 K(-152.4%)
-$13.00 K(-43.5%)
Mar 2011
-
-$21.00 K(+600.0%)
-$23.00 K(-90.1%)
Dec 2010
-$233.00 K(-108.1%)
-$3000.00(<-9900.0%)
-$233.00 K(-49.2%)
Sep 2010
-
$0.00(-100.0%)
-$459.00 K(-32.7%)
Jun 2010
-
$1000.00(-100.4%)
-$682.00 K(-121.6%)
Mar 2010
-
-$231.00 K(+0.9%)
$3.16 M(+10.0%)
Dec 2009
$2.88 M(-237.7%)
-$229.00 K(+2.7%)
$2.88 M(+10.1%)
Sep 2009
-
-$223.00 K(-105.8%)
$2.61 M(+14.7%)
Jun 2009
-
$3.85 M(-842.7%)
$2.28 M(-210.9%)
Mar 2009
-
-$518.00 K(+4.9%)
-$2.06 M(-1.7%)
Dec 2008
-$2.09 M(-111.5%)
-$494.00 K(-11.3%)
-$2.09 M(+155.5%)
Sep 2008
-
-$557.00 K(+14.6%)
-$818.00 K(+213.4%)
Jun 2008
-
-$486.00 K(-12.1%)
-$261.00 K(-101.5%)
Mar 2008
-
-$553.00 K(-171.1%)
$17.27 M(-4.7%)
Dec 2007
$18.12 M(-65.5%)
$778.00 K(>+9900.0%)
$18.12 M(+1.9%)
Sep 2007
-
$0.00(-100.0%)
$17.79 M(-0.0%)
Jun 2007
-
$17.05 M(+5639.7%)
$17.79 M(+2278.7%)
Mar 2007
-
$297.00 K(-33.0%)
$748.00 K(-98.6%)
Dec 2006
$52.50 M(+40.5%)
$443.00 K(+7283.3%)
$52.50 M(-7.0%)
Sep 2006
-
$6000.00(+200.0%)
$56.43 M(-0.1%)
Jun 2006
-
$2000.00(-100.0%)
$56.51 M(-0.1%)
Mar 2006
-
$52.05 M(+1091.6%)
$56.58 M(+51.4%)
Dec 2005
$37.38 M(+713.1%)
$4.37 M(+4863.6%)
$37.38 M(-9.2%)
Sep 2005
-
$88.00 K(+12.8%)
$41.17 M(+0.2%)
Jun 2005
-
$78.00 K(-99.8%)
$41.09 M(+9.7%)
Mar 2005
-
$32.84 M(+302.3%)
$37.44 M(+714.5%)
Dec 2004
$4.60 M(-64.5%)
$8.16 M(<-9900.0%)
$4.60 M(-229.6%)
Sep 2004
-
-$2000.00(-99.9%)
-$3.55 M(-137.7%)
Jun 2004
-
-$3.57 M(<-9900.0%)
$9.42 M(-27.2%)
Mar 2004
-
$0.00(-100.0%)
$12.94 M(-0.1%)
Dec 2003
$12.95 M(+7518.2%)
$20.00 K(-99.8%)
$12.95 M(+0.0%)
Sep 2003
-
$12.96 M(<-9900.0%)
$12.95 M(<-9900.0%)
Jun 2003
-
-$42.00 K(-481.8%)
-$14.00 K(-108.6%)
Mar 2003
-
$11.00 K(-35.3%)
$163.00 K(-4.1%)
Dec 2002
$170.00 K(+11.1%)
$17.00 K(>+9900.0%)
$170.00 K(-13.7%)
Sep 2002
-
$0.00(-100.0%)
$197.00 K(-13.2%)
Jun 2002
-
$135.00 K(+650.0%)
$227.00 K(+54.4%)
Mar 2002
-
$18.00 K(-59.1%)
$147.00 K(-3.9%)
Dec 2001
$153.00 K(-99.8%)
$44.00 K(+46.7%)
$153.00 K(-99.7%)
Sep 2001
-
$30.00 K(-45.5%)
$60.75 M(-0.3%)
Jun 2001
-
$55.00 K(+129.2%)
$60.91 M(-35.3%)
Mar 2001
-
$24.00 K(-100.0%)
$94.07 M(-3.4%)
Dec 2000
$97.37 M(>+9900.0%)
$60.64 M(>+9900.0%)
$97.37 M(+165.1%)
Sep 2000
-
$185.00 K(-99.4%)
$36.73 M(+0.5%)
Jun 2000
-
$33.22 M(+900.0%)
$36.54 M(+999.7%)
Mar 2000
-
$3.32 M(>+9900.0%)
$3.32 M(>+9900.0%)
Dec 1999
$312.00 K
-
-
Jun 1999
-
$1000.00(>+9900.0%)
$1000.00(>+9900.0%)
Mar 1999
-
$0.00
$0.00

FAQ

  • What is Insmed Incorporated annual cash flow from financing activities?
  • What is the all time high annual CFF for Insmed Incorporated?
  • What is Insmed Incorporated annual CFF year-on-year change?
  • What is Insmed Incorporated quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Insmed Incorporated?
  • What is Insmed Incorporated quarterly CFF year-on-year change?
  • What is Insmed Incorporated TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Insmed Incorporated?
  • What is Insmed Incorporated TTM CFF year-on-year change?

What is Insmed Incorporated annual cash flow from financing activities?

The current annual CFF of INSM is $1.34 B

What is the all time high annual CFF for Insmed Incorporated?

Insmed Incorporated all-time high annual cash flow from financing activities is $1.34 B

What is Insmed Incorporated annual CFF year-on-year change?

Over the past year, INSM annual cash flow from financing activities has changed by +$1.17 B (+696.15%)

What is Insmed Incorporated quarterly cash flow from financing activities?

The current quarterly CFF of INSM is $159.31 M

What is the all time high quarterly CFF for Insmed Incorporated?

Insmed Incorporated all-time high quarterly cash flow from financing activities is $781.49 M

What is Insmed Incorporated quarterly CFF year-on-year change?

Over the past year, INSM quarterly cash flow from financing activities has changed by +$36.04 M (+29.24%)

What is Insmed Incorporated TTM cash flow from financing activities?

The current TTM CFF of INSM is $1.34 B

What is the all time high TTM CFF for Insmed Incorporated?

Insmed Incorporated all-time high TTM cash flow from financing activities is $1.34 B

What is Insmed Incorporated TTM CFF year-on-year change?

Over the past year, INSM TTM cash flow from financing activities has changed by +$1.17 B (+696.15%)